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Abstract  
Mutational robustness is the extent to which an organism has evolved to withstand 
the effects of deleterious mutations.  We explored the extent of mutational 
robustness in the budding yeast by genome wide dosage suppressor analysis of 53 
conditional lethal mutations in cell division cycle and RNA synthesis related genes, 
revealing 660 suppressor interactions of which 642 are novel.  This collection has 
several distinctive features, including high co-occurrence of mutant-suppressor 
pairs within protein modules, highly correlated functions between the pairs, and 
higher diversity of functions among the co-suppressors than previously observed.  
Dosage suppression of essential genes encoding RNA polymerase subunits and 
chromosome cohesion complex suggest a surprising degree of functional plasticity of 
macromolecular complexes and the existence of degenerate pathways for 
circumventing potentially lethal mutations.  The utility of dosage-suppressor 
networks is illustrated by the discovery of a novel connection between chromosome 
cohesion-condensation pathways involving homologous recombination, and 
Huntington’s disease. 
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 Biological interaction networks are robust to perturbation1,2,3,4,5 because of several 
features, including power-law network topology, redundancy, modularity, and their 
dynamic properties2,6,7,8,9,10,11,12,13,14,15,16,17. Although modularity is a common feature of 
interaction networks12,18,19,20,21,22, the contribution of modularity to genetic robustness is 
difficult to determine.  Recent studies have revealed dynamic interaction among 
apparently unrelated gene modules in response to genotoxic stress, suggesting the 
existence of highly reconfigurable networks of gene and protein modules as well as of 
unexpectedly plastic macromolecular complexes19.  Rewiring of signaling and/or 
metabolic networks have been observed in cancer cells that evolved chemotherapy 
resistance23,24. It has been speculated that genetic and epigenetic changes could 
accomplish network rewiring25,26. Complex genomic changes reminiscent of functional 
rewiring are associated with rapid evolutionary adaptation in response to mutation in an 
essential gene27. 
 The suppression of essential gene mutations has been classically employed to 
investigate gene function, and suppressors provide clues to mechanisms of evolution28. 
More recently, genome wide dosage suppressor discovery has contributed novel insights 
into biological processes29,30. By seeking dosage suppressors of 53 mutant genes, mostly 
encoding cell cycle/DNA replication related genes or RNA polymerase/RNA 
modification related genes, we have uncovered 660 pairs of “dosage-suppressor” 
interactions, which supplement 1,626 dosage-suppressor pairs reported previously in the 
literature31 and 254 interactions that were discovered in a recent high throughput 
experiment29. The set of interaction pairs discovered in this study overlaps significantly 
with known protein-protein and genetic interaction pairs, suggesting related molecular 
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mechanisms that connect the suppressed mutant gene product with the suppressor gene’s 
product. The mutant-suppressor pairs tend to belong to the same protein-protein 
interaction modules as determined by several independent criteria. We confirm all 
previously noted mechanisms of suppression29, including stabilization of heat sensitive 
macromolecular complexes by over-producing a physically interacting protein partner 
(Fig. 1a), stabilization of unfolded heat sensitive proteins by chaperones, and modulation 
of expression of other genes participating in the same biological process as affected by 
the mutant gene.  Here we present evidence of at least one additional mechanism of 
network robustness, namely, the existence of degenerate pathways. The utility of dosage-
suppression network is illustrated by the serendipitous discovery of a novel connection 
between chromosome cohesion-condensation pathways and the toxic effects of the 
Huntington’s disease protein. 
 
Results 
 
A genome-wide screen for dosage suppressors 
 We transformed 108 isogenic yeast strains each containing a temperature sensitive 
(ts) point mutation (85 mutants) or a ts deletion mutation (23 mutants)32 with pools of the 
entire MORF (Movable Open Reading Frame) library plasmids (Materials and Methods, 
Supplementary Table S1). The use of this library permits interrogating every conditional 
mutant with virtually every yeast ORF, under conditions where each ORF is expressed in 
the presence of galactose or glucose (Fig. 1b-d). We transformed each mutant strain with 
high copy 2μ based plasmids expressing open reading frames (ORFs) under pGAL 
promoter control33, selected transformants at the permissive temperature (250C), then 
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tested for the ability of the recombinant plasmids to rescue growth defect above the 
specific restrictive temperature for the corresponding mutant strain (see Methods). Each 
candidate suppressor ORF was individually confirmed by multiple retransformation 
experiments, and a subset by sequencing. In this manner we obtained 660 confirmed 
dosage suppressor interactions for 53 of the 108 ts mutants we tested (Fig. 1c, 
Supplementary Table S2), involving 517 suppressor genes, all of which were individually 
confirmed through retransformation and repeats of the assays, with all suppressors of a 
third of the mutant strains collection having been independently confirmed twice at two 
different sites (Rochester and KGI). 642 out of 660 interactions are novel; 18 were 
reported earlier.  We did not detect 147 interactions previously reported in the literature 
corresponding to the 53 query mutants (Supplementary Table S3. We directly tested 57 of 
these previously reported suppressor interactions (corresponding to seven query mutant 
genes), chosen arbitrarily from among the 147 interactions that we did not discover, and 
were able to confirm by our methods only 15/57 interactions (Supplementary Table S4).  
These observations suggest that strain background and allele differences, copy number of 
the plasmids used for suppression, and/or the levels of galactose-induced gene expression 
obtainable by these various methods are sufficiently different such that a direct 
comparison is not possible.  Therefore each case of validated suppression should be 
considered as a suppression event that is true under at least one set of conditions. 
 
General properties of the dosage-suppressor network 
 The dosage suppressor network discovered here (dataset DS-A), containing 53 ts 
mutants and 517 suppressor genes, exhibits a large connected component (560 nodes, 656 
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edges) (Supplementary Fig. S2) that excludes 29 nodes and 20 edges. Of the 517 
suppressor genes, 134 are of unknown function at the time of writing. Previous work29 
had examined the entire collection of dosage suppressors of essential gene mutants 
known at the time (dataset DS-B, in BioGrid), including 214 suppressor genes they 
discovered for 29 mutants (dataset DS-C). All three network datasets together (DS-ABC) 
comprise 2,286 dosage-suppressor interactions (Fig. 2; Cytoscape network output file: 
http://tinyurl.com/kmsb6nm). 
 We examined the functional similarity of the genes discovered through this study 
with those in previous studies in the following way. We mapped the genes of each of the 
three networks on to a curated and integrated protein-protein interaction (PPI) 
network18,34,35,36,37 (see Methods), and calculated topological properties of the 
corresponding protein nodes in this PPI network (Supplementary Table S5).  DS-A 
comprising 660 interactions overlapped significantly with the PPI network (P=2.8 x 10-15, 
see Tables 1, S5, and S6). This overlap, though significant, is small: 3.4% (23/660) of the 
dosage suppressor interactions in this work are edges in the PPI network compared with 
19.5% (445/2,286, including 45 reciprocals) for DS-ABC (Fisher’s exact P < 0.0001).  
The previous dosage-suppressor collection (DS-A and DS-B) also showed a statistically 
significant overlap with the curated PPI. The degree and clustering coefficient of the 
dosage suppressor gene nodes in the PPI network are not significantly different among 
the three DS datasets. By contrast, the values of another topological property, 
betweenness centrality (BC; see Methods for definition) of the nodes in DS-A or DS-C 
are significantly higher than the nodes in DS-B (Supplementary Table S5).  Moreover, 
the mutant-suppressor gene pairs are not statistically enriched for co-expression or for 
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genes with similar evolutionary age (Table 1), again suggesting functionally different 
mechanisms than stabilization by PPI, for which the interacting protein pairs tend to 
possess correlated gene expression patterns38 and similar evolutionary ages39.  A 
statistically significant overlap with PPI network implies that the mutant-suppressor pairs 
may belong to the same protein modules or complexes (below, we explicitly examine this 
question).  However, the relatively small, though statistically significant, overlap of DS-
A with the PPI network implies that DS-A is qualitatively different from DS-B or DS-C.  
Since a common mechanism of dosage suppression in the previously described 
suppressor networks was rescue of protein function through protein-protein contact29, the 
present results open the possibility that a significant proportion of dosage suppressors 
discovered in this work might suppress through other mechanisms.   
 
Modular organization in dosage-suppressor network 
 Biological networks have underlying modular sub-structures that reflect 
functional organization and evolutionary origins of gene products38,40. Because there is no 
unambiguous definition of a module within protein networks, we here examine three 
concepts of modularity that are intrinsically different. First, we examined protein 
complexes that are manually curated clusters obtained from physical protein-protein 
interaction data41 (See Methods for the integrated PPI dataset), and determined the 
overlap of the 660 mutant-suppressor pairs with these complexes31,41 .  The products of 
54 pairs of the 660 dosage-suppressor pairs were found within the same protein 
interaction complexes (binomial P < 10-15) (Table 1).  When the entire collection of 2,286 
dosage-suppressor pairs known so far (DS-ABC) was so examined, 558 pairs co-occur in 
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the same protein complexes (binomial P < 10-15). Second, modules were obtained by 
computationally optimizing a modularity measure on the PPI network42, and similar 
associations were observed within the computationally predicted PPI clusters (Table 1). 
Third, we identified modules dynamically, by sequentially removing genes from a 
curated PPI network constructed from the dosage suppressor pairs (see Methods), starting 
with the highest BC gene, and re-computing the BC of nodes in each resulting network, 
leading to a measure of modularity43. Gene pairs that predominantly lie within modules 
should remain connected in the PPI network longer than the average pair, while gene 
pairs that straddle modules should separate earlier. Throughout this iterative process the 
mutant-suppressor pairs in DS-A were more likely to be found within module boundaries 
(Wilcoxon rank-sum P=2.26 × 10-14; Supplementary Fig. S4) than were the randomly 
chosen protein pairs, even more so than the pairs in DS-C29 (P=1.55 × 10-13) or those DS-
B (P=2.14× 10-10).  That the mutant-suppressor pairs lie preferentially within module 
boundaries is consistent with the observed distribution of mutant-suppressor distances 
within the PPI network (number of edges along the shortest path in the PPI network 
connecting the mutant to the suppressor; see inset in Supplementary Fig. S4). 
 To determine the identity of the complexes within which the mutant-suppressor 
pairs co-occur, we culled from BioGRID database 4,632 direct PPIs, and used Netcarto 
module clustering algorithm42 to generate 41 modules (Supplementary Table S7).  We 
queried each mutant-suppressor pair discovered in DS-A for their co-occurrence in these 
41 modules, and found eight such modules containing five clusters and three singletons 
(Fig. 3a-e). In one module (Fig. 3a), mutations in cell cycle control genes cdc28 (a CDK), 
cdc20 and cdc16 (both anaphase promoting complex protein genes), and cdc37 (encodes 
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an HSP90 co-chaperone), are suppressed by several genes including a ribosomal protein 
gene MRPL50, and MPD1 that encodes an endoplasmic reticulum chaperone interacting 
protein, underscoring the importance of molecular chaperones and ribosomal proteins in 
facilitating the suppression of point mutant alleles.  In a second module (Fig. 3b), 
mutations in cdc9 (DNA ligase), tfb3 (transcription coupled DNA repair), and pob3 
(encodes a member of the FACT complex for nucleosome reorganization) are in the same 
module with several suppressors including ADE2 (purine biosynthesis), PSY3 (DNA 
repair-recombination), and SSL2 (DNA repair helicase). While it is surprising that an 
adenine biosynthesis gene ADE2 is a suppressor of cdc9, Ade2p has predicted protein-
protein interactions with Cdc9p, Pob3p, Tfb3p, and Ssl2p, suggesting that the 
suppression of cdc9 by ADE2 likely has a biological basis through the DNA repair-
recombination pathway. When this module is expanded by querying the yeast integrated 
genetic and physical interaction network44 with members of this module, the network 
output provides further indirect evidence for linking the purine biosynthesis related genes 
to DNA repair-recombination (Supplementary Fig. S3). These results demonstrate the 
utility of using modules instructed by the dosage-suppressor network for novel gene-
function discovery. 
 
Functional similarity within mutant-suppressor pairs 
 Dosage suppressor genes and their corresponding suppressed mutant genes are 
functionally related.  120 out of 660 mutant-suppressor pairs in DS-A shared the same 
gold standard gene ontology (GO)45 terms (binomial P <10-15), and 922 of 2286 known 
mutant-suppressor pairs (in DS-ABC) shared the same (binomial P < 10-15) 
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(Supplementary Table S8).  The mutant-suppressor pairs have similar GO molecular 
functions (P = 6.02 x 10-4 for the 660 pairs in DS-A, and P < 10-15 for DS-ABC) and 
similar GO biological process (Wilcoxon rank-sum P = 1.88 x 10-12 for DS-A, and P < 
10-15 for DS-ABC). 
 To test whether the dosage-suppressor pairs are enriched for other types of genetic 
interactions, we intersected these pairs with known genetic interaction pairs reported in 
the literature46, and found significant enrichment (P = 5.34 x 10-8) for 11 kinds of genetic 
interactions considered by Costanzo et al46 (Supplementary Table S9).  For 30 of the 660 
gene pairs in DS-A (~4.5%), a previously reported genetic interaction was found to exist, 
including 18 pairs of dosage-suppressor interactions, one each of positive genetic 
interaction and phenotypic suppression, seven negative genetic interactions, 11 synthetic 
lethal/rescue or growth defect interactions, and three phenotypic enhancements.  A large 
fraction (547/660) was not found to overlap with known physical or genetic interaction 
pairs, thus reinforcing the previous conclusion that dosage-suppressor data provide 
additional information on biological function of genes that are not provided by other 
types of genetic interaction data29. 
 
Co-suppressors are functionally diverse 
 We analyzed whether co-suppressors (suppressors of the same ts mutant) are 
functionally related to each other.  First, suppressors in DS-A are not significantly 
enriched (Fisher’s exact P = 0.65) for paralogs: only 93 out of 517 genes in the 
suppressor network have at least one known paralog, as determined by the curated list of 
“ohnologs” (paralogs descended from whole genome duplication events)47.  Among the 
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93 paralogs, we found 20 paralogous partners within mutant-suppressor sets (Table 2).  
We determined functional similarity between proteins by comparing their MIPS (Munich 
Information Center for Protein Sequences, http://www.helmholtz-
muenchen.de/en/mips/services/index.html) functional catalog annotations48. Functional 
similarity, defined by the functional congruence (see Methods) of a ts-mutant gene with 
its suppressors, is significantly lower than that which would be expected for proteins 
having a direct physical interaction (Wilconxon rank-sum P=2.26 x 10-14) 
(Supplementary Fig. S5A). As a comparison, the functional congruence between a ts-
mutant and its suppressors is also lower for DS-C network than that for DS-B (BioGrid), 
whereas that of DS-B is comparable to that in the curated PPI network (Supplementary 
Fig. S5A).  These observations suggest that DS-A and DS-C reveal suppressors that are 
qualitatively different from those revealed by the focused methods used by earlier 
workers, which predominate in DS-B.  Moreover, the functional congruence among co-
suppressors of the same mutant in DS-A is comparable with the congruence between 
proteins that share a physical edge in the curated PPI network (Supplementary Fig. S5B).  
However, the co-suppressors of the same mutant for DS-A are considerably more diverse 
than those in DS-B or DS-C (Supplementary Fig. S5B), once again demonstrating a 
distinct collection of dosage-suppressors discovered here. We schematically illustrate this 
diversity in Supplementary Fig. S6. 
 
Plasticity and robustness of RNA polymerase II complex  
 To test how often genes whose products are known to function within the same 
macromolecular complex can suppress mutations that affect products within the same or 
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related complexes, we chose as a test bed a well studied protein machine—the RNA 
polymerase II (RNA Pol II) complex49. RNA Pol II core (12 subunits) is recruited to the 
promoter by the general transcription factors TBP, TFIIA and TFIIB (1 subunit each), 
and TFIIF (3 subunits), with the help of the SRB/mediator complex (25 subunits), to form 
the pre-initiation complex, following which TFIIE (2 subunits) and TFIIH (9 subunits) 
are recruited50. The SWI/SNF (11 subunits) and SAGA (22 subunits) complexes facilitate 
chromatin remodeling during transcription initiation49.  Extensive genetic interaction 
studies among mediator complex proteins have been reported51. We scanned eight mutant 
genes, each of which encoded a defective (or had a complete loss of one) transcription 
initiation complex protein52,53, for gene dosage suppression by 75 sub-complex genes 
(Supplementary Table S10; Supplementary Fig. S7).  Six mutants were temperature 
sensitive (ts) lethal due to missense mutation (med4, med11, tfb3, rad3, kin28, taf12); two 
were ts deletion mutants (rpb4−Δ, and taf14−Δ).  The deletion mutants had complete 
deletion of the respective structural genes, such that there was no possibility of 
expression of any remnant protein fragment32,54. 
 31 out of 122 dosage suppressor-mutant interactions in DS-A reside within the 
respective complexes.  For example, MED11, NUT1, GAL11, ROX3, SRB5, and SRB7 
each suppressed med4 (Fig. 4a).  By contrast, nearly three times as many mutant-
suppressor interaction pairs (91/122 compared to 31/122; P = 0.0001 by Fisher’s exact 
test) overlapped two separate sub-complexes (e.g., suppression of med4 by TFB3 of 
TFIIH complex and RPC10 of Pol II core complex, respectively).  Suppressor 
interactions were specific: e.g., TFA1 (TFIIE complex) suppressed med4 but not 
med11—both of the latter encode mediator proteins. Similarly, SNF11 and SNF12 of the 
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SWI/SNF complex each suppressed tfb3 but not kin28 (TFIIH); RPO21 (Pol II core) 
suppressed both tfb3 and kin28. 
 We discovered 36 suppressors of the eight RNA Pol II gene mutations, which are 
not known to be members of the RNA Pol II complex genes (Supplementary Table S2).  
The most striking example involves taf14−Δ (Fig. 4b), which yielded 27 suppressors, 
most of them encoding proteins outside the RNA Pol II complex, 12 of which are genes 
of unknown function.  While the co-suppressor network of taf14−Δ was not enriched in 
PPI, a number of negative and positive epistatic edges connect several co-suppressors, 
including several genes of unknown function, to RNA Pol II complex genes.  These 
results demonstrate the remarkable ability of this essential protein machine to function 
despite drastic genetic perturbations. 
 
Suppressors of a chromosome condensation defect illustrate molecular rewiring 
 The genome wide suppressor dataset allowed us to explore suppression 
mechanisms quite different from that of the RNA Polymerase II findings discussed 
above: we provide examples wherein increased expression of genes allowed the bypass of 
an essential gene function by engaging alternate genetic pathways.  Results described 
below show that the suppression of smc2 mutation by at least two different suppressor 
genes appear to proceed through this general mechanism, including the engaging of 
proteins important for or control of meiosis to an otherwise mitotic cellular division 
cycle. 
 Smc2p is a DNA-binding subunit of the Smc2p/Smc4p condensin complex55,56,57 
required for sister chromatid (SC) alignment, separation, and inhibiting SC recombination 
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during mitosis55,58.  We identified four strong dosage suppressors of smc2: UME1, 
MEK1, HTA2, and SNU66 (Fig. 5a).  Strikingly, the first two are known to play mutually 
opposing functional roles59,60,61—UME1 is a mitotically expressed gene required for the 
repression of a subset of meiotic genes, including those important for meiotic 
homologous recombination, and MEK1 is a meiosis specific protein kinase that promotes 
meiotic homologous recombination by suppressing sister chromatid (SC) recombination.  
To provide more insights into the mechanisms of suppression, we analyzed the time 
course of mRNA expression by these four suppressed smc2-8 mutant strains at the 
restrictive temperature and compared their global gene expression patterns with that of 
the mutant complemented by pGAL:SMC2 (See Methods). 
 Results (Fig. 5b-c) show that all four suppressors partially induce the expression 
of some meiosis-related genes.  This led us to propose and test a simple model of smc2 
dosage suppression mechanism, in which meiosis specific genes rescue smc2 defects in 
mitosis (Fig. 5d-e):  smc2 mutation, which causes a failure of chromosome condensation 
in mitosis, allows the initiation but not the resolution of SC recombination, thus blocking 
mitosis55. Ectopic expression of meiosis-specific genes in the suppressed strains either 
prevents precocious SC recombination or resolves the SC recombination intermediates 
allowing mitotic division to progress.  This model is a particular instance of the general 
mechanism shown in Fig. 1a by genes f and g.  Specifically, a non-essential meiotic gene 
module controlling recombination replaces the essential mitotic gene module controlling 
chromosome condensation.  We tested an implication of this hypothesis by introducing 
37 MORF clones (Supplementary Table S12) corresponding to two categories of genes 
into smc2-8 and assaying their ability to suppress the ts growth defect: (a) other SMC 
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complex genes, and (b) several meiotic recombination-promoting genes. 29/37 genes so 
tested suppressed smc2-8 (examples shown in Fig. 5d). Among those that suppressed 
smc2-8, were RAD51, DMC1, and MND1—all three are recombination-promoting genes, 
although RAD51 was a weak suppressor, and all suppressions were galactose 
independent.  Several intron-containing meiosis-specific recombination genes, including 
DMC1 and MND1, are expressed and spliced to the mature form at low levels in mitosis 
but are expressed highly and spliced efficiently in meiosis62. The function of DMC1 is to 
promote recombination between homologous chromosomes and also to inhibit SC 
exchange in meiosis63.  Dmc1p participates in a cascade of reactions activated through 
phosphorylation by Mek1p60, which we have found also to be a suppressor of smc2.  
These results support the idea that at least one mechanism of suppression of smc2 is 
through mitotic expression of meiotic recombination genes, which are expected to 
prevent the formation of or to promote the resolution of sister-chromatid junctions that 
occur at high frequency in smc2 mitosis. 
 
A link between chromosome condensation-cohesion pathways and 
Huntington’s disease 
 A query of combined PPI and genetic interaction databases with six genes—smc2 
and its five suppressors UME1, BNA5, SCC4, SMC1, and SMC3—generated an 
interaction network of 26 genes (including SCC2) containing three functional modules 
(enrichment significance, all Benjamini-Hochberg (B-H) corrected: chromatin 
remodeling complex, P = 2.37 x 10-5; sister chromatid cohesion complex, P = 1.38 x 10-7; 
and chromosome condensation, P = 6.4 x 10-13) (Fig. 6a).  The members of each module 
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exhibit extensive PPI and genetic interactions with members of the other two modules. 
We noticed that SCC2 encodes a member of the HEAT repeat proteins, which include 
Huntingtin (Htt)—a protein with expanded poly-glutamine residues in the N-terminal 
region that polymerizes to an insoluble aggregate (plaque) in certain brain cells of 
Huntington’s disease patients64. Moreover, BNA5 is a suppressor that linked two 
functional modules (Fig. 6a). A previous study65 had identified 28 deletion mutations that 
suppressed Htt toxicity in yeast, which included ume1Δ and bna4Δ, both of which have 
mammalian homologs.  The transcriptional repressor Ume1p requires for its activity 
Rpd3p59, a part of the histone deacetylase (HDAC) complex. The inhibition of Rpd3 
HDAC complex by Ume1p increases the toxicity of mutant human Htt in yeast, where 
Htt toxicity was related also to the function of BNA4 and BNA566.  The latter two genes 
encode two successive enzymes in the NAD biosynthetic pathway from kynurenine, and 
the BNA4 product is a target for therapy against Huntington’s disease67,68,69. These results 
are consistent with the hypothesis that Htt toxicity is related to the chromosome 
condensation-cohesion processes, and might be influenced by homologous recombination 
pathways. We tested one prediction of this hypothesis by attempting to suppress Htt 
toxicity by SMC2, suppressors of smc2-8, and cohesin/condensin genes (Fig. 6b): 9 of 14 
genes so tested suppressed Htt toxicity (SMC1, SMC3, SMC4, SCC4, MEK1, UME1, 
DMC1, HTA2, and MND1 suppressed; SMC2, SCC1, SCC3, CWC24 and RAD51 did 
not). 
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Discussion 
 A genome wide network of dosage suppressors allowed us to explore functional 
relatedness among the co-suppressors. Mapping of the mutant-suppressor pairs on a PPI 
network revealed boundaries of topologically defined protein modules.  By examining 
specific protein modules through suppressors of selected RNA Pol II gene mutants, we 
found that high expression of specific component proteins within large protein assemblies 
can functionally replace the absence or the reduction of specific essential components.  
These latter results underscore the importance of including systematic dosage suppression 
data in deriving systems-level models of large protein complexes and their pathways of 
self-assembly. 
 In principle, dosage-suppressor interactions may involve high affinity and high 
probability protein-protein interactions that enable the system to return to the original 
state by positive and/or negative feedback effects (buffering interactions). In one 
scenario, over-produced suppressor products stabilize the corresponding thermo-sensitive 
missense mutant protein by direct interaction, through recruiting functionally competent 
folding intermediates from a distribution of folded states. By contrast, suppressors of 
deletion mutations, such as those of rpb4−Δ and taf14−Δ, in which the entire coding 
frames were deleted, cannot possibly exert their effects by stabilization through direct 
protein-protein interaction. Surprisingly, deletion ts alleles had a similar average 
frequency of suppressors (121 interactions with 10 mutants) as did missense ts alleles 
(539 interactions with 43 mutants).  This suggests that heat sensitive biological processes 
(for ts deletion mutations) are as suppressible as processes catalyzed by individual heat-
sensitive proteins (for ts missense mutations). Thus, the suppression mechanisms of 
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rpb4−Δ by RPB3 (RNA Pol II core), and by ROX3 (mediator) likely involve direct or 
indirect functional replacement of Rpb4p.  One mechanism might be the stabilization of 
the RNA Pol II preinitiation complex by the over-expression of one of the component 
proteins, such that the preinitiation complex rendered heat labile by rpb4−Δ is made more 
robust by an overabundance of Rpb3p or Rox3p.  A similar argument holds for the 
suppression of taf14−Δ by TAF2, TAF13, and TAF10 (all TFIID), TFB3 (TFIIH), SRB7, 
PGD1, CSE2 (all mediator/SRB), SPT3 (SAGA), and by SNF5 and SNF6 (both 
SWI/SNF).  Such alternate functional replacements within and between protein 
complexes reflect a high degree of compositional plasticity, and might also imply 
alternate pathways of assembly of multi-protein complexes. These observations are 
generally consistent with the recent observation that RNA Pol II open complexes can be 
reactivated by the TFIIE complex through stabilizing effects on relatively unstructured 
domains on mediator proteins70. Such “Intrinsically Disordered Regions” serve to 
functionally assemble RNA pol II complex subunit proteins54,71 and thus provide a high 
degree of modular functionality. 
 Although 45 of 53 suppressed mutant alleles are missense mutations, and several 
suppressors encode protein folding or processing enzymes such as chaperones or heat 
shock proteins (HSC82, HSP32, and CCT6) or chaperone interacting protein (MPD1), 
there is no significant statistical enrichment for these classes of proteins in the dataset 
produced in this work. By contrast, there is a significant enrichment for ribosomal 
proteins in our dataset (B-H corrected P = 2.64 x 10-4) as in the full set of known dosage 
suppressors (B-H corrected P = 4.5 x 10-6). The suppression of cdc37 (a co-chaperone 
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mutant) by RPS18A, RPL25, and RPS24B is consistent with the possibility that some 
ribosomal proteins may have weak chaperone-like activity72. 
 Some suppressors of smc2-8 appear to act through direct protein-protein 
interaction with the mutant protein.  For example, SMC1 and SMC3, required for SC 
cohesion, but not the condensin gene SMC4, can suppress smc2-8 (Fig. 5d).  Protein-
protein interaction between the mutant Smc2-8p and Smc1p/Smc3p cohesin complex 
might be able to stabilize misfolded Smc2-8p, whereas direct interaction between Smc2-
8p and Smc4p, both members of the condensing complex, cannot do so.  A recent report 
indicates that Smc2p homolog from S. pombe interacts with the S. pombe histone H2A 
and H2A.Z proteins in recruiting the condensin proteins to mitotic chromosomes73.  Since 
S. cerevisiae HTA2 encodes a homolog of S. pombe H2A gene family, it is possible that 
Hta2p also recruits Smc2p to the nucleosome in an analogous manner.  If true, at least a 
part of the suppression mechanism by HTA2 might be explained by the stabilization of 
mutant Smc2p through direct protein-protein interaction with Hta2p.  Note that snu66 and 
hta2 mutations genetically interact46, suggesting that the mechanisms of suppression of 
smc2-8 by the two corresponding wild type genes might indeed be mutually related.  
Snu66p interacts with Snu40p46,74, and Snu40p in its turn interacts with proteins involved 
in chromosome condensation and cohesion, including Scc3p 75.  Scc3p is part of the 
Smc1p-Smc3p-Scc1p-Scc3p cohesin complex, which interacts with the Smc2p-Smc4p 
condensin complex, and the latter is stabilized by Scc2p-Scc4p complex.  Therefore, one 
mechanism might be the stabilization and recruitment of thermosensitive Smc2-8p 
subunits into the condensin complex by direct protein-protein interaction with a cohesin 
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complex protein that includes Scc4p.  The suppression of smc2-8 by SCC4 is consistent 
with this mechanism. 
 Dosage suppression by rewiring, in contrast to that by direct PPI, may involve 
low affinity and/or low probability interactions that illustrate alternative—redundant or 
degenerate—pathways.  These pathways of suppression appear to decouple physical 
interaction modules from the modules of functional activities, and the flexible interaction 
edges rearrange the functional modules to buffer the effects of genetic and environmental 
perturbations. We presented evidence that a mitotic chromosome condensation defect can 
be bypassed by ectopic expression of a series of meiotic genes involved in controlling 
sister chromatid recombination and resolution of recombination intermediates, suggesting 
that a defective biological process can be bypassed by alternate biological processes that 
are not engaged in cells during normal function.  We proposed and tested a model in 
which the mitotic blockage by the smc2 mutation could be bypassed by UME1, MEK1, 
HTA2, and SNU66, by either preventing SC recombination initiation or augmenting SC 
recombination resolution; the predicted model was tested by further findings that several 
meiotic recombination genes DMC1, MND1, and RAD51 also suppressed smc2.  Since 
SNU66, a strong suppressor of smc2, encodes a splicing component, it is possible that the 
over-expression of Snu66p augments the splicing of DMC1 and MND1 pre-mRNAs in 
mitotic cells. 
 Suppressor interactions that connect BNA4/5 to UME1, SCC2, and SMC2, point to 
a possible mode of action of the mutant Huntingtin protein involving the chromosome 
condensation/cohesion process. As a test of this hypothesis, we examined the ability of a 
set of suppressors of smc2-8 mutation (including SMC2) to also suppress 103Q toxicity, 
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and discovered that several cohesin/condensin genes, and a few homologous 
recombination genes including MND1, are able to do so. Interference by Htt of the 
normal sister-chromatid cohesion process could potentially increase somatic 
recombination at CAG repeats, and thus might underlie the observed variable penetrance 
of high poly-glutamine expansion alleles on disease onset age in humans76,77.  Consistent 
with this speculation, a recent report has linked a network of ploidy control genes in yeast 
to Htt toxicity78. 
 An unresolved question remains as to the extent of genetic robustness that is 
hardwired in the genome, which was first brought to the fore by the investigation of 
mutational effects on the lysis-lysogny decision circuit of bacteriophage lambda79.  In this 
work, mechanisms of suppression of a defect in chromosome condensation revealed 
insights on the potential of unrelated genes that could be brought to bear on solving 
problems associated with defective cellular processes. It is conceivable that yeasts in 
nature, and organisms in general, depend on the rewiring of gene regulatory circuits to 
find new solutions to essential cellular processes during evolution under selective 
pressure, as observed in this work that meiotic genes relieve mitosis blockage. Such a 
possibility was investigated earlier in evolved yeast strains with a deletion in an essential 
gene (myo1), where aneuploidy and large-scale variation in the transcriptome were 
associated with survival27. While aneuploidy was a recurrent theme observed in that 
work, it was also estimated that the number of available genetic solutions to a lethal 
perturbation might be limited.  Gene redundancy80, and promiscuity of gene function30,81 
both contribute to genetic robustness. While the core set of essential genes might impede 
evolvability82, modular rewiring may in principle overcome this barrier83.  Our finding 
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that nearly six times as many genes can suppress 53 deleterious mutations indicates a 
high degree of robustness built into the genome, and illustrates potential pathways for 
rewiring of the genome.  It is conceivable that a deleterious mutation in an essential gene, 
leading to growth arrest, is followed by genomic changes that are often observed in 
stationary phase cells27,84,85,86,87; these changes could in principle activate suppressor 
pathways to restore viability and provide adaptation.   
 The network of dosage suppressors of essential gene mutants is analogous to the 
network of genes that could potentially bypass, if aberrantly expressed, a drug target gene 
function (e.g., of a cancer-essential gene) for tumor cell survival. Such a network for a 
cancer cell is the equivalent of potential pathways for developing resistance to cancer 
chemotherapy, or, analogously, for evolving independence from the checkpoints that 
ensure non-proliferative growth, which evidently occurs frequently during the 
development of cancers. 
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Materials and methods 
MORF plasmids  The movable open reading frame (MORF) library33 containing 
5,871 2μ plasmids with galactose inducible promoter and a URA3 selectable marker were 
divided into 16 pools. Each pool, representing approximately 384 plasmids, was grown in 
96 deep-well plates, pooled, and plasmid DNA samples were isolated for transformation. 
Yeast strains, media and transformation Temperature sensitive lethal Saccharomyces 
cerevisiae strains had specific mutations in BY4741 background (MATa his3-Δ1 leu2-Δ0 
met15-Δ0 ura3-Δ0); point mutants were provided by Dr. Charlie Boone (University of 
Toronto) and ts deletion mutants were screened and selected from the deletion mutant 
library (OpenBiosystem). For each mutant, the range of growth and the threshold of non-
permissive temperature on both inducing (+ galactose) and non-inducing (- galactose) 
conditions were determined. Yeast strains were grown in yeast complete media 
containing 1% raffinose, transformed with 1μg of each MORF plasmid pool, and plated 
at permissive temperature on synthetic defined medium lacking uracil with 1% raffinose. 
The transformants from 16 plates were pooled and selected at the restrictive temperature 
for that particular ts allele on complete and synthetic media containing either 2% glucose 
(repression) or 2% galactose (induction) (see Supplementary Table S1) for a list of 
restrictive temperatures corresponding to the ts alleles).  The threshold restrictive 
temperature that cuts off the growth of each individual allele with or without (vector 
control) the candidate suppressor plasmid was determined for each suppressor by 
incubating identical multiple-replicate plates at a range of temperatures spanning at least 
±20C around the restrictive temperature for that allele. Transformants in each mutant 
strain were selected for growth above the respective restrictive temperature characteristic 
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for the corresponding mutant strain containing the empty vector plasmid. Strains for 
testing suppression of Htt toxicity were in W303 background88 (can1-100, his3-
11,15::FLAGhtt103Q-CFP,leu2-3,112trp1-1,ura3-1, ade2-1; and can1-100, his3-
11,15::FLAGhtt25Q-CFP, leu2-3,112trp1-1,ura3-1,ade2-1). 
Suppressor identification and confirmation Suppressor candidate hits were 
identified by microarray hybridization of isolated plasmid DNA from colonies growing 
above the restrictive temperature for the respective ts allele as follows: Approximately 
300 colonies were picked from selection plates at restrictive temperature, grown in 96 
deep-well plates. The cells were pooled and plasmid DNA isolated using Cycle Pure Kit 
from Omega Bio-Tek, and labeled with Cy3 dye, whereas the pooled DNA of the MORF 
library was labeled with Cy5 by PCR amplification using two flanking primers 
(5’GGACCTTGAAAAAGAACTTC3’, 5’CCTCTATACTTTAACGTCAAGG3’). 
Labeled probes were hybridized to spotted microarrays (UHN Microarray; containing > 
95% of all ORFs) at 65 OC for 16 h. Microarrays were scanned in Bio-Rad VersArray 
Chip Reader and the data were analyzed using ScanArray express software 3.0 (Perkin 
Elmer).  For a limited number of suppressors, we purified the DNA from colonies 
growing on selection plates with raffinose and galactose, transformed into E. coli, re-
isolated the corresponding plasmid DNA samples, PCR amplified the ORF off the MORF 
plasmids, and sequenced the DNA.  In all cases, the suppressor MORFs identified by 
sequencing were identical to the MORFs identified by microarray hybridization.  The 
putative suppressor genes identified by either microarray or by direct sequencing were 
retransformed individually to the respective mutant strains, their ability to suppress the 
mutants confirmed individually on at least three separate transformed colonies by 
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isolating single colonies and testing on inducing or non-inducing plates at a range of 
temperatures above the growth cutoff temperature of the corresponding unsuppressed 
mutant, dependence of suppression on the introduced MORF plasmid was confirmed for 
each transformant on plates containing 5-fluroorotic acid, and for those transformants 
passing all above tests the titration-spotting test was carried out for final 
confirmation/quantification of suppressor strength. The background strain was always 
compared on the same plate with the candidate-suppressed strains at a range of 
temperatures spanning at least 10C over the corresponding threshold temperature for 
growth of the given mutant. The extent of suppression was subsequently quantified 
through spotting of serial dilutions of each mutant/suppressor culture under both inducing 
and noninducing conditions. A subset of the final list of suppressors was again confirmed 
by sequencing.  The negative control for each suppressor was the corresponding mutant 
strain carrying the empty MORF vector (BG1776).  Positive control plasmids were the 
complementing genes under pGAL control, except for six mutants (cdc13, cdc4, cdc15, 
cdc35, cdc48, and abd1) that did not have the appropriate positive controls because either 
the over-expression of the corresponding MORF plasmids was lethal (CDC13, and 
CDC48) or they were absent in the MORF library (CDC4, CDC15, CDC35, and ABD1).  
The strength of suppression for each suppressor was normalized to the growth of the 
diluted spots against that of the corresponding vector control (BG1776) strain on the 
same plate on adjacent rows (Supplementary Table S2). 
Protein detection Cultures were grown in repressing and inducing media, and whole 
cell extracts were prepared by the bead beating method in yeast lysis buffer (25 mM 
Hepes-NaOH pH 7.5, 10 mM NaCl, 1 mM EDTA, 0.1% Triton X-100) containing 
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EDTA–free complete protease inhibitor tablet (Roche). Proteins were detected by 
Western Blotting, probed by anti-HA antibodies (Covance) using standard methods. 
Liquid growth assay Growth curves in liquid media along with maximal growth rates 
were determined using a Bioscreen C Automated Growth Curves Analysis System 
(Growth Curves USA). The suppressed strains were grown in 200 μl of S-URA with 1% 
raffinose and 2% galactose at various temperatures in 96-well plates. The optical density 
(OD) was measured at 600 nm every 30 minutes for 48 hours of growth. 
RNA methods Strains were grown in 5 mL S-URA media containing 2% raffinose 
for 24 hours at 28°C. Samples were diluted to OD 0.02 in 150 mL S-URA media 
containing 2% raffinose and 2% galactose, and then grown overnight at 25°C with 
agitation. At OD 0.1, cultures were shifted to 34.5°C with continuous agitation, and 
samples were harvested at 0, 45, 90 and 180 min by centrifugation. Total RNA was 
isolated using a hot phenol method 89, followed by 2 chloroform extractions, RNA 
precipitated by addition of 1/10th volume of NaOAc pH 5.2, and 2.5 volumes of 100% 
ethanol and the pellet dissolved in 50μL ddH2O. Total RNA was deproteinized again 
after DNase treatment and resuspended in 10 μL of ddH2O, and quantified by a nanodrop 
spectrophotometer. 
Gene expression measurements 1 μg total RNA samples from two individual 
biological replicates, four time points each (0, 45, 90 and 180 min), of smc2-8 mutant 
strains harboring pGAL:SMC2, pGAL:UME1, pGAL:MEK1, pGAL:HTA2, 
pGAL:SNU66, and the negative control MORF plasmid (pGAL:negative, BG1766), were 
reverse transcribed, hybridized to Affymetrix Yeast Genome S98 arrays and scanned with 
Affymetrix GeneChip Scanner 3000. The microarray data were analyzed with 
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GeneSpring 6.2 software, and were deposited in Gene Expression Omnibus (accession 
number GSE24266). Microarray expression levels were verified for 7 reference genes by 
quantitative RT-PCR using samples of a third biological replicate (Supplementary Fig. 
S8). 
Microarray Data Analysis The Affymetrix array data were processed using the Robust 
Multi-array Analysis (RMA) as described previously90.  A log scale, linear additive 
model represented the perfect match and mismatch data.  For each experiment (time point 
or condition), the RMA analysis produced one numerical estimate of expression for every 
probe on the chip (two replicates for each treatment and time point).  We combined the 
replicates using a median based normalization (given microarray replicates 1 and 2, 
determined the median intensities m1 and m2 of microarray 1 and microarray 2 
respectively; adjusted the values of microarray 2 by adding m1  – m2 to the intensities of 
microarray 2) to produce an average of the adjusted intensities.  For each time point and 
treatment we produced one intensity measurement for each probe.   These numbers were 
used to find ratios of fold change from one time point to the next. For each chip, a 
background noise intensity measure was formed using the average intensity of the 
SPACER probes which act as a set of negative controls for the chip – if for a particular 
probe, the intensity level at time points t1 and t2 was below the background noise level at 
t1 and t2, then we assumed the probe was expressing at background noise level and the 
fold change was set to 1.  We clustered genes that were significantly differentially 
expressed in at least one time point. 
Quantitative RT-PCR DNase treated RNA was reverse transcribed in 25 µL RT 
reaction mixtures (1x First Strand Buffer, 0.02 μg random hexamers, 0.01 M DTT, 0.5 
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mM dNTP mix, 0.6 U RNaseOUT, containing 3 U Superscript II Reverse Transcriptase) 
for 2 h at 37 ºC, followed by heat inactivation at 100ºC for 5 min and quick chilling on 
ice.  A standard curve was generated for each gene target starting with 0.5 μg RNA, and 
four successive 2-fold serial dilutions. The cDNA templates generated by reverse 
transcription was used for quantitative RT-PCR in Applied Biosystems 7500 FAST Real 
Time PCR system. The PCR mix constitutes 20 µL buffer containing 1X FAST SYBR 
Green Master Mix and 0.2 μM forward and reverse primers (IDT), with the PCR 
conditions: [95°C → 20 sec] HOLD, [95°C 3 sec → 60°C 30 sec] 40 times). The 
following primers were used for real time PCR of seven genes: 
Table: List of Primers for Real Time Quantitative PCR 
OPT2 Forward Primer GGG CTT TGA ATT TGT GGG CCA TGA 
OPT2 Reverse Primer TCA TAA TCG TCG AGC GCC CTG TAA 
SMC2 Forward Primer AAC TTG TGC CGG AGG TAG GCT ATT 
SMC2 Reverse Primer GCC AAT TCA ACT TTC CCA GGA GCA 
PHO5 Forward Primer AGA CAT GCT CGT GAC TTC TTG GCT 
PHO5 Reverse Primer AAG CAC TCA AAG TGT TGG CAC CAG 
CYC7 Forward Primer AGT ACG GGA TTC AAA CCA GGC TCT 
CYC7 Reverse Primer GTC CAA CTT TGT TAG GAC CAC CCT 
GRE1 Forward Primer ACT GGT GGT GGC ACT TAT ACC CAA 
GRE1 Reverse Primer TGG TAG CGG TTA CTT TGA GCA CCT 
SIP18 Forward Primer AGG GAA AGA ACG CCA AAT CCT CCA 
SIP18 Reverse Primer CAA TCG TTC GCA ATT CCT CTG CCA 
FIT1 Forward Primer TGC CCA ATC TGT TCG TAC CCA TGA 
FIT1 Reverse Primer ACC AGC GGT AGT GGT TTG AAC TCT 
 
Datasets  
   
 29
The full Dosage Suppressor (DS) dataset (DS-ABC, see text), consisting of data reported 
here combined with other available data, was culled from the following sources: 
Magtanong et al.29, the latest BioGRID version 3.1.78 31, and this work (660 dosage 
suppressor interactions between 53 mutant ORFs and 517 suppressor ORFs). The full DS 
dataset contains 2286 interactions between 454 mutant ORFS and 1284 suppressor 
ORFS, and includes 60 reciprocal interactions, resulting in 2226 unique interactions. The 
PPI network was constructed from BioGRID version 3.1.78 31 that contains 6,614 ORFs 
of which 5,955 nodes are connected by physical interaction edges. The 99,866 physical 
interactions produced 60,143 unique edges among 5,728 nodes. This network was curated 
to filter out indirect physical interactions and retain only the direct physical interaction 
data from eight types of experiments including Biochemical activity, co-crystal structures 
and reconstituted complexes, PCA, protein-peptide interactions, two-hybrid, far western 
and FRET. The resulting direct PPI network, containing a total of 20,034 unique 
interactions between 4683 nodes, was used for studying the enrichment of PPI 
interactions in the dosage-suppressor (DS) network (Supplementary Table S6). Genetic 
interaction (GI) data was downloaded using the latest BioGRID version 3.1.7831, which 
contains eleven kinds of genetic interactions, namely, Dosage growth defect, Lethality, 
Dosage Rescue, Negative Genetic, Phenotypic Enhancement, Phenotypic Suppression, 
Positive Genetic, Synthetic Growth Defect, Synthetic Haplo-insufficiency, Synthetic 
Lethality, and Synthetic Rescue. In all, the GI dataset includes 16898 interactions 
between 5411 nodes. The Stanford Microarray Database was used for inferring co-
expression between yeast ORFs at a correlation coefficient cut-off of ±0.5. The resultant 
co-expression network includes 623,224 unique edges between 5155 nodes from total 
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643 experiments reported by two groups91,92. Genome-wide protein complex data was 
inferred by combining the Curated Yeast Complexes (CYC2008), a comprehensive 
catalogue of manually curated 408 heteromeric protein complexes in S. cerevisiae with 
400 complexes in the Annotated Yeast High Throughput (YHTP) complexes derived 
from high-throughput Tandem Affinity Purification/Mass Spectrometry (TAP/MS) 
studies41, and 72,016 pairs of indirect physical interactions from Affinity Capture, Co-
Fractionation, Co-purification and Co-localization experiments (BioGRID version 
3.1.78). The Pfam domains for many yeast proteins have been assigned one of four age 
groups ABE, AE/BE, E and F depending on their taxonomic distribution among archaea 
(A), bacteria (B), eukaryote (E) and fungi (F)93. This dataset was used to analyze whether 
DS pairs were likely to belong to the same age group. Both the DS datasets were tested 
for significant overlap with computationally predicted modules. For this, 41 Yeast 
Louvain modules were identified in the Yeast direct PPI network by using the NetCarto 
algorithm42.  In addition, Markovian clusters were identified using the MCL-MLR 
clustering method 94 at an inflation value of 2.4. 
Paralog identification The list of paralogs (554 gene pairs) was described 
before47, and includes 457 pairs previously found95. Of the 1,108 paralogous genes, 1,001 
were represented in the MORF library. To test for significant enrichment of paralogs, we 
performed a Fisher’s exact test using the 5,829 testable ORFs as the baseline.  
Network properties Betweenness centrality (BC) (fraction of shortest paths through a 
node) was , where  is the ratio of the number of shortest paths between a 
pair of nodes in the network that pass through node i.  BC was scaled as 
B' i = bi
all pairs

bi
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Bi =
2B'i
(n −1)(n − 2)
, where n is the number of nodes in the network96. Clustering 
coefficient (ratio of the actual number of degrees of a node to the possible degrees given 
a node’s neighbors), and shortest path between pairs were computed using the MATLAB 
Boost Graph Library toolset.  
Functional congruence assessment  Functional gene annotations were derived 
from the MIPS FunCat database48. 449 of the 642 unique suppressors were annotated 
genes. Un-annotated genes (class ‘99’) were excluded. Here, functional congruence 
between two genes is defined as the extent of overlap between their respective MIPS 
annotations. Because MIPS functional annotations are hierarchical categories, we studied 
the congruence of MIPS annotations based on the 1st category alone, 1st and 2nd, 1st, 2nd, 
and 3rd, etc. categories, down to congruence in all 5 categories. Because genes can have 
several MIPS annotations, we compiled the possible pairs of categories for each pair of 
genes and calculated the fraction of pairs of annotations that agreed, divided by the 
number of possible pairs of annotations. Because many annotations do not include details 
up to the fifth functional categorization, we devised rules to match annotation strings of 
different length. For example, when matching the functional MIPS annotation 
“01.01.05.01.02” (degradation of polyamines) with “01.01.06” (metabolism of the 
aspartate family), we pad annotations such that the previous example would result in a 
match at level 1, a match at level 2, but not at level 3 and beyond. In other words, for 
incomplete annotation the omitted part is assumed to be different from that of any other 
annotations.  The functional congruence of two genes at level n is the fraction of 
annotations of these genes that are identical up to level n. By design, the functional 
congruence of a pair at level n is larger or equal to the functional congruence of that pair 
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at level n+1.  
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Figure legends 
 
Fig. 1: Dosage suppression of essential gene mutations. (a) X and Y are cellular 
processes, of which X but not Y is essential for viability. X normally requires the 
function of genes a-e. Gene e is regulated (blue arrows) by a complex of proteins (black 
lines, PPI) encoded by genes a-d. Y is regulated by g and f. If a is mutated to a 
conditional allele (red), over-expression of either b or c (but not d) may stabilize 
sufficient properly folded mutant a proteins, causing suppression (green arrows). If gene 
a deletion causes ts lethality, and if over-expression of b, c, or d causes suppression, then 
the structural modularity of components within the complex enables suppression. If the 
over-expression of f and/or g also suppresses a and/or e, then genes f and/or g can also 
control process X through a promiscuous mechanism (dashed arrow). Suppression by f 
and g reveals functional modularity. (b) The strategy for isolating dosage suppressors of 
ts lethal mutations. See Methods for details. (c) A few examples of suppressors of 
different strengths.  A ts allele of cdc36 is viable at 250C, but fails to grow above 330C, is 
complemented by pGAL:CDC36 at 350C or below under all tested conditions (galactose 
independent), and is suppressed by MATα2 (strong, grade 4), MTH1 (medium-weak, 
grade 2), CCL1 (strong, grade 5), and ASF2 (strong, grade 5). The latter two genes 
exhibit galactose independent suppression.  YNL324W is a very weak suppressor (grade 
1, reproducible).  pGAL-negative is the vector control. (d) Summary of the screen. Most 
suppressors were effective on galactose but not on glucose (Tables S2); a few exceptional 
suppressors are galactose independent (see above), presumably because these expressed 
detectable quantities of MORF-encoded protein even on glucose (see Supplementary Fig. 
S1 for examples). 
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Fig. 2: Dosage suppressor interaction network in yeast. This network contains 454 ts 
lethal mutations that are suppressed by 1,284 genes, representing 2,286 interactions.  
Nodes are either essential gene mutations or their suppressors, and the directed edges 
(color and thickness weighted by edge-betweenness centrality) are dosage suppressor 
interactions. Many suppressors are likely specific to the experimental conditions adopted 
here, and at least a subset may be allele specific.  Alternate experimental methods may 
reveal additional suppressors. The data contain 660 novel interactions reported here, 
added to those listed in BioGrid and those reported by Magtanong et al.29. 
 
Fig. 3:  Mutant-suppressor pairs are enriched within protein modules.  Five 
computationally predicted modules in which specific mutant-suppressor pairs are 
statistically enriched are shown. The Netcarto algorithm returned a total of 41 modules 
for the 660 ORF pairs in dataset A. Of these, 71 pairs of ORFs lie within modules 
(Supplementary Table S7). Node color: purple, mutant genes; all remaining nodes are 
suppressors, arbitrarily colored according to their functional annotations. Edge colors: 
green, genetic interaction; gray, dosage suppressor interaction; purple, co-expression; 
yellow, shared protein domains; brown, physical interaction.  
 
Fig. 4:  Dosage suppressors of RNA Pol II mutants. (a) Suppression of RNA Pol II 
mutants. We chose eight ts mutant genes (RNA Pol II core complex: rpb4-D; mediator 
complex: med4 and med11; TFIID: taf12 and taf14-D; TFIIH: rad3, tfb3 and kin28) and 
scanned these for dosage suppression by 75 RNA polymerase II complex genes. Dosage 
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suppressors (at the base of each arrow) of mutant proteins (at the head of each arrow) are 
indicated. Not all sub-complex proteins are shown. Arrow denotes dosage suppression. 
Example titration results are in Supplementary Fig. S7.  (b) Co-suppression network of 
taf14-Δ as derived from genome wide dosage suppressor screen. Edge color: yellow, 
dosage suppression; green, genetic interaction; blue, PPI. 
 
Fig. 5:  Network rewiring as a mechanism of suppression. (a) Cell cycle checkpoint arrest 
by smc2-8 at the restrictive temperature is suppressed by galactose-induced expression of 
UME1, MEK1, HTA2, and SNU66. (b) Growth curves of the suppressed strains. Smc2-8 
strains harboring pGAL:SMC2, pGAL:UME1, pGAL:MEK1, pGAL:HTA2, 
pGAL:SNU66, and the negative control MORF plasmid (pGAL:negative, BG1766), 
respectively. Samples taken from these cultures were used in gene expression profiling. 
(c) Heat map of differentially expressed genes. Normalized log2 transformed mRNA 
levels of genes were re-normalized against corresponding expression levels in the 
negative control strain, the resulting expression ratios were filtered for signals above ±2σ 
and hierarchically clustered. The first four time points are log2 ratios of expression values 
of smc2-8/pGAL:SMC2 to that of smc2-8/pGAL negative control plasmid.  The 
remaining lanes are log2 ratios of expression values of smc2-8/pGAL:UME1, smc2-
8/pGAL:MEK1, smc2-8/pGAL:HTA2, and smc2-8/pGAL:SNU66, respectively, to that 
of smc2-8/pGAL:SMC2. (d) Results of a focused screen for additional smc2-8 
suppressors. Only a few suppressors of various strengths are shown. (e) Mechanisms of 
smc2-8 suppression deduced from the phenotype and suppression network. 
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Fig. 6: Dosage suppressor network illuminates Huntington’s disease mechanisms. (a) 
Modules discovered by querying combined genetic and physical interaction network of 
yeast with suppressors of smc2, showing a link through BNA5. (b) Example results of a 
test that suppressors of chromosome cohesion/condensation defects in smc2-8 mutant 
also suppress expanded poly-Q toxicity of the Huntington’s disease protein Htt. Yeast 
strains carrying a chromosomal copy of either normal (25Q) or expanded (103Q) allele of 
the human Htt N-terminal fragment, expressed through the pGAL promoter, were 
transformed with MORF plasmids and tested for suppression of 103Q toxicity. Strains 
that express toxicity fail to grow on media containing galactose. Suppression of toxic Htt 
by HTA1 was reported before97, so served as a positive control. Here, MND1, SMC1, and 
SMC3 suppressed Htt toxicity but SMC2 did not. See text for complete results. 
 
.  
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Table 1 
Similarities between mutant genes and their suppressors 
 
 
Number of mutant-
suppressor gene 
pairs  
Among dosage suppressor 
pairs (total 660) discovered 
in this work 
Among all known dosage suppressor 
pairs (total, 2286) 
Number Enrichment 
significance 
(Binomial one-
sided test P) 
Number Enrichment 
significance 
(Binomial one-sided 
test P) 
With direct PPI 23 2.8 x 10-15  445 <10-15 
Co-located in the 
same protein 
complex 
54 <10-15 558 < 10-15 
Co-located in the 
same 
computationally 
predicted protein 
module# 
71 8.6 x 10-6 557 <10-15 
Co-located within 
the same PPI 
cluster## 
12 2.4 x 10-5 232 <10-15 
In which both 
genes are co-
expressed 
10 0.263097* 
 
144 3.1 x 10-12 
In which both 
genes are of similar 
evolutionary age 
159 0.06422174* 
 
641 1.8 x 10-10 
*No statistically significant enrichment 
#Co-located in one of 41 Louvain modules, computed by the Netcarto algorithm 42 
##Co-located in Markovian clusters, computed by MCL-MLR clustering 94. 
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Table 2 
 
Paralogous pairs of dosage suppressors 
 
Paralog 1 Mutation(s) suppressed 
by paralog 1 
Paralog 2 Mutation(s) suppressed by 
paralog 2 
YBR181C cdc24, cdc15 YPL090C cdc24, cdc15, poc4 
YCR073W-A cdc26 YNR034W cdc26 
YDR099W cdc25 YER177W cdc25 
YDR471W pol5 YHR010W pol5, cdc25 
YER056C-A cdc48 YIL052C cdc48 
YER131W vrp1 YGL189C vrp1 
YFR023W smc2 YHR015W smc2 
YJL177W cdc48 YKL180W cdc48, cdc13 
YLL062C taf14 YPL273W taf14, cdc13 
YLR029C cdc24, cdc26 YMR121C cdc24 
  
a            b             c
                    d
YGL238W
YKR055WYDR002W
YKL092C
YJL031C
YKR022C
YLR424W
YDL229W
YDR123C
YNL227C
YER074W−A
YGR172C
YHR165C
YPL069C
YNR049C
YDR086C
YNL189W
YIL140W
YAR042W
YBR058C−A
YFR004W
YBR171W
YNL263C
YMR292W
YPL094C
YGR196C
YOR254C
YPL145C
YHR073W
YDL019CYLR378CYKR090W
YOR127WYBR098W
YNL266W
YER143W
YEL061C
YDR418W
YDR524C
YOL080C
YNL158W
YOR148C
YPL245W
YGL182C
YOL123W
YLR053C
YJR039W
YDR417C
YML097C
YDR266C
YLR073CYJR038C
YPR133W−AYPL205CYLR117C
YNL230CYLR379WYDR526C
YDR500C
YKL202W YLR051C
YJR050W
YOR338WYAL034W−A
YDL020C
YDL132W
YKL180W
YLR274W
YPR102C
YDR099W
YDL028C
YNL069C
YGL073W
YNL289W
YFL033C
YER177W
YMR273C
YER167W
YJL106W
YER120W
YJR076C
YBR087W
YNL126W
YBL072C
YML109W
YHR172W
YEL032W
YBL011W
YER173W
YEL034W
YJR068W
YBL081W YER126C
YBR172C
YBR080C
YBR202W
YDR293C
YER129W
YOR010C
YLR314C
YHR115C
YBR118W
YLR094C
YOR372C
YER007C−A
YAL003W
YDL071C
YDR172W
YOR359W
YML092C
YIL172C
YBR119W
YOR060C
YJR044C
YGR287C
YPR023C
YGL113W
YPL018W
YLR333CYPR150W
YBL083CYJL091C
YPL233W
YEL059W
YDR339C
YNL007C
YPL242C
YHR023W
YBR004C
YAL005C
YER144C
YIL150C
YJR154W
YML110C
YER081W
YKL078W
YCR048W
YER088C
YIR010W
YBL062W
YER026CYBL054W
YNL255C YEL027W
YJR008WYOR215C
YNR048W
YGL093W
YAL056W
YHR171WYLR103C
YLR025W
YOR371C
YPL241C
YBL075C
YOR295W
YOL064C
YPL171C
YGR175C
YER074W
YDR382W
YJL061W
YMR309C
YLL004W
YOL126C
YDL117W
YER112W
YMR032W
YNL152W
YPL177C
YBR212W
YDR495C
YLR276C
YOR310C
YFL056C
YER056C−A
YMR067C
YJL044C
YBL092W
YML091C
YBL066C
YMR203WYGR107W
YPL034W
YAL069WYGR147C
YLR101C
YMR308C
YDR395W
YOR045W
YLR441C
YOR182C
YPL237W
YHL015W
YDR177W
YBR082C
YPR171W
YJR006W YLL047W
YDL064W
YKL165C
YNL169C
YGR170W
YKL112W
YBR078W
YLL031C
YBL026WYLR438C−A
YDR192CYIR002C
YKL113C
YNL218W
YOR033C
YOR260W
YHR164C
YDL207W
YEL035C
YNL245CYBL051C
YJR022W
YDL182WYOL020W
YNR038W
YMR255W
YHR179W
YBL050W
YAL041W
YLR249W
YDL150WYIL061C
YGL103W
YML041CYJL177W
YGR048W
YJL151CYIL052C
YDR449C
YDR512C
YDL160C
YKR059W
YNL110C
YOR255W
YMR242C
YDL126C
YGR014W
YGR242W
YOR132W
YIL096C
YPL184C
YMR121C
YOL112WYMR043W
YBL034C
YDR014W
YMR184W
YLR354C
YBR060C
YDL122W
YBL035C
YGR118W
YGR093W
YNL175C
YKL122C
YDR412W
YBR143C
YPL093W
YBR034C
YDR521W
YMR013C
YFR042W
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